ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

4 links0 made here, not in the record6 judgments1 judge (the rules as one: Rule based)0 record changes seen
Rule based
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07385989Golidocitinib Combined WithP-GemOx Plus PD-1 InhibitorVersus P-GemOx Plus PD-1Inhibitor in First-LineNewly Diagnosed Advanced orNon-Nasal ExtranodalNK/T-Cell LymphomaWEI XUPhase 2 · not yet recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSLymphoma, Extranodal NK-T-C…The registry's MeSH filing›As of now · Rule based · Main conditionMain conditionDRUGSGolidocitinibEntry “Golidocitinib in combination w…›As of now · Rule based · TestedTestedINT012089Entry “Golidocitinib in combination w…›As of now · Rule based · TestedAs of now · Rule based · ComparatorComparatorImmune checkpoint inhibitorsEntry “Golidocitinib in combination w…›As of now · Rule based · TestedAs of now · Rule based · ComparatorComparator

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Lymphoma, Extranodal NK-T-Cell

From the registry record1 judgment on this link
Main condition (R9), from the registry to what was judged
RegistryLymphoma, Extranodal NK-T-Cell, as filedthe registry files the study under it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
As of nowLymphoma, Extranodal NK-T-CellRule based · main-condition ruleMain conditionCurrent
As of nowGolidocitinibRule based · role ruleTestedCurrent
As of nowINT012089Rule based · role ruleTestedCurrent
As of nowINT012089Rule based · role ruleComparatorCurrent
As of nowImmune checkpoint inhibitorsRule based · role ruleTestedCurrent
As of nowImmune checkpoint inhibitorsRule based · role ruleComparatorCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.